Učitavanje...
Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
BACKGROUND: Tetrabenazine is the only US Food and Drug Administration‐approved drug for Huntington's disease, and deutetrabenazine was recently tested against placebo. A switching‐trial from tetrabenazine to deutetrabenazine is underway, but no head‐to‐head, blinded, randomized controlled trial...
Spremljeno u:
| Izdano u: | Mov Disord Clin Pract |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5573977/ https://ncbi.nlm.nih.gov/pubmed/28920068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12483 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|